These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

511 related items for PubMed ID: 26493253

  • 1. Paclitaxel-Coated Balloon in Infrapopliteal Arteries: 12-Month Results From the BIOLUX P-II Randomized Trial (BIOTRONIK'S-First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularization of infrapopliteal arteries).
    Zeller T, Beschorner U, Pilger E, Bosiers M, Deloose K, Peeters P, Scheinert D, Schulte KL, Rastan A, Brodmann M.
    JACC Cardiovasc Interv; 2015 Oct; 8(12):1614-22. PubMed ID: 26493253
    [Abstract] [Full Text] [Related]

  • 2. IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial.
    Zeller T, Baumgartner I, Scheinert D, Brodmann M, Bosiers M, Micari A, Peeters P, Vermassen F, Landini M, IN.PACT DEEP Trial Investigators.
    Trials; 2014 Feb 19; 15():63. PubMed ID: 24552184
    [Abstract] [Full Text] [Related]

  • 3. The IN.PACT DEEP Clinical Drug-Coated Balloon Trial: 5-Year Outcomes.
    Zeller T, Micari A, Scheinert D, Baumgartner I, Bosiers M, Vermassen FEG, Banyai M, Shishehbor MH, Wang H, Brodmann M, IN.PACT DEEP Trial Investigators.
    JACC Cardiovasc Interv; 2020 Feb 24; 13(4):431-443. PubMed ID: 32081236
    [Abstract] [Full Text] [Related]

  • 4. The "DEBELLUM"--lower limb multilevel treatment with drug eluting balloon--randomized trial: 1-year results.
    Fanelli F, Cannavale A, Corona M, Lucatelli P, Wlderk A, Salvatori FM.
    J Cardiovasc Surg (Torino); 2014 Apr 24; 55(2):207-16. PubMed ID: 24670828
    [Abstract] [Full Text] [Related]

  • 5. Outcomes After Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Patients With Critical Limb Ischemia: A Post Hoc Analysis From the IN.PACT Global Study.
    Reijnen MMPJ, van Wijck I, Zeller T, Micari A, Veroux P, Keirse K, Lee SW, Li P, Voulgaraki D, Holewijn S.
    J Endovasc Ther; 2019 Jun 24; 26(3):305-315. PubMed ID: 30931726
    [Abstract] [Full Text] [Related]

  • 6. Drug-eluting balloons for femoropopliteal lesions show better performance in de novo stenosis or occlusion than in restenosis.
    Herten M, Torsello GB, Schönefeld E, Imm B, Osada N, Stahlhoff S.
    J Vasc Surg; 2015 Feb 24; 61(2):394-9. PubMed ID: 25307133
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and one-year outcomes of Luminor® paclitaxel-coated drug-eluting balloon in the treatment of popliteal artery atherosclerosis lesions.
    Pecoraro F, Dinoto E, Pakeliani D, Mirabella D, Ferlito F, Bajardi G.
    Ann Vasc Surg; 2021 Oct 24; 76():370-377. PubMed ID: 33951533
    [Abstract] [Full Text] [Related]

  • 8. Single-Center Experience With Lutonix Drug-Coated Balloons in Infrapopliteal Arteries.
    Steiner S, Schmidt A, Bausback Y, Bräunlich S, Ulrich M, Banning-Eichenseer U, Scheinert D.
    J Endovasc Ther; 2016 Jun 24; 23(3):417-23. PubMed ID: 27099285
    [Abstract] [Full Text] [Related]

  • 9. Paclitaxel-coated balloon angioplasty versus drug-eluting stenting for the treatment of infrapopliteal long-segment arterial occlusive disease: the IDEAS randomized controlled trial.
    Siablis D, Kitrou PM, Spiliopoulos S, Katsanos K, Karnabatidis D.
    JACC Cardiovasc Interv; 2014 Sep 24; 7(9):1048-56. PubMed ID: 25234679
    [Abstract] [Full Text] [Related]

  • 10. Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery).
    Liistro F, Grotti S, Porto I, Angioli P, Ricci L, Ducci K, Falsini G, Ventoruzzo G, Turini F, Bellandi G, Bolognese L.
    JACC Cardiovasc Interv; 2013 Dec 24; 6(12):1295-302. PubMed ID: 24239203
    [Abstract] [Full Text] [Related]

  • 11. Primary Self-EXPANDing Nitinol Stenting vs Balloon Angioplasty With Optional Bailout Stenting for the Treatment of Infrapopliteal Artery Disease in Patients With Severe Intermittent Claudication or Critical Limb Ischemia (EXPAND Study).
    Schulte KL, Pilger E, Schellong S, Tan KT, Baumann F, Langhoff R, Torsello G, Zeller T, Amendt K, Brodmann M, EXPAND Investigators.
    J Endovasc Ther; 2015 Oct 24; 22(5):690-7. PubMed ID: 26245919
    [Abstract] [Full Text] [Related]

  • 12. The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty.
    Scheinert D, Duda S, Zeller T, Krankenberg H, Ricke J, Bosiers M, Tepe G, Naisbitt S, Rosenfield K.
    JACC Cardiovasc Interv; 2014 Jan 24; 7(1):10-9. PubMed ID: 24456716
    [Abstract] [Full Text] [Related]

  • 13. Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial.
    Kinstner CM, Lammer J, Willfort-Ehringer A, Matzek W, Gschwandtner M, Javor D, Funovics M, Schoder M, Koppensteiner R, Loewe C, Ristl R, Wolf F.
    JACC Cardiovasc Interv; 2016 Jul 11; 9(13):1386-92. PubMed ID: 27388828
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. One-Year Clinical Outcomes of the Legflow Drug-Coated Balloon for the Treatment of Femoropopliteal Occlusions Registry.
    Stabile E, Gerardi D, Magliulo F, Zhelev D, Chervenkoff V, Taeymans K, Kotasov D, Goverde P, Giugliano G, Trimarco B, Esposito G.
    J Endovasc Ther; 2019 Feb 11; 26(1):26-30. PubMed ID: 30760132
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. German Center Subanalysis of the LEVANT 2 Global Randomized Study of the Lutonix Drug-Coated Balloon in the Treatment of Femoropopliteal Occlusive Disease.
    Scheinert D, Schmidt A, Zeller T, Müller-Hülsbeck S, Sixt S, Schröder H, Weiss N, Ketelsen D, Ricke J, Steiner S, Rosenfield K.
    J Endovasc Ther; 2016 Jun 11; 23(3):409-16. PubMed ID: 27117972
    [Abstract] [Full Text] [Related]

  • 19. Long-Term Clinical Effectiveness of a Drug-Coated Balloon for the Treatment of Femoropopliteal Lesions.
    Laird JA, Schneider PA, Jaff MR, Brodmann M, Zeller T, Metzger DC, Krishnan P, Scheinert D, Micari A, Wang H, Masters M, Tepe G.
    Circ Cardiovasc Interv; 2019 Jun 11; 12(6):e007702. PubMed ID: 31195825
    [Abstract] [Full Text] [Related]

  • 20. Drug-Coated Balloon Treatment of Femoropopliteal Lesions for Patients With Intermittent Claudication and Ischemic Rest Pain: 2-Year Results From the IN.PACT Global Study.
    Micari A, Brodmann M, Keirse K, Peeters P, Tepe G, Frost M, Wang H, Zeller T, IN.PACT Global Study Investigators.
    JACC Cardiovasc Interv; 2018 May 28; 11(10):945-953. PubMed ID: 29798770
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.